Literature DB >> 8399503

Use of a Dublin inner city A & E department by patients with known HIV-1 infection.

N Desmond1, M Murphy, P Plunkett, F Mulcahy.   

Abstract

During the period January 1990 to January 1992 260 patients known to be infected with human immunodeficiency virus type 1 (HIV-1) attended the Accident & Emergency (A & E) Department of St James's Hospital, Dublin. There was a total of 709 visits with a mean annual attendance rate of 2.7, twice that for the general A & E population. Eighty-nine per cent of patients were intravenous drug users (IVDUs), 9% homosexual/bisexual and 2% heterosexual. Known HIV-1 seropositive patients accounted for 0.7% and 0.8% of the total number of patients who attended A & E in 1990 and 1991 respectively. The majority of patients disclosed their HIV status. Bacterial respiratory tract infection was the single most common reason for attending A & E and for admission to hospital. Seventy-two per cent of IVDUs fulfilled Centers of Disease Control (CDC) criteria for stage II and III disease; the majority of these used A & E for primary medical care, although listed with a general practitioner (GP) and attending during the daytime. Sixty-eight per cent of homosexuals/bisexuals were CDC stage IV with AIDS defining illnesses accounting for 52.6% of clinical presentations. Of this risk category, 79% required medical admission. Homosexuals/bisexuals represent more advanced disease, thus the full impact of HIV-1 infection in IVDUs in this A & E setting has yet to be realized.

Entities:  

Mesh:

Year:  1993        PMID: 8399503     DOI: 10.1177/095646249300400409

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Opiate overdose in Dublin.

Authors:  W Cullen; S Griffin; G Bury; P K Plunkett
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

2.  HIV malingering in the accident and emergency department.

Authors:  J Ryan; C B Taylor; G D Bryant; A T Nayagam; J Sanders
Journal:  J Accid Emerg Med       Date:  1995-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.